Your browser doesn't support javascript.
loading
Kidney Function and Risk of Renal Cell Carcinoma.
Alcala, Karine; Zahed, Hana; Cortez Cardoso Penha, Ricardo; Alcala, Nicolas; Robbins, Hilary A; Smith-Byrne, Karl; Martin, Richard M; Muller, David C; Brennan, Paul; Johansson, Mattias.
Afiliação
  • Alcala K; Genomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France.
  • Zahed H; Genomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France.
  • Cortez Cardoso Penha R; Genomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France.
  • Alcala N; Genomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France.
  • Robbins HA; Genomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France.
  • Smith-Byrne K; Cancer Epidemiology Unit, Oxford Population Health, University of Oxford, Oxford, United Kingdom.
  • Martin RM; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
  • Muller DC; NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, United Kingdom.
  • Brennan P; Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.
  • Johansson M; Imperial College London, London, United Kingdom.
Cancer Epidemiol Biomarkers Prev ; 32(11): 1644-1650, 2023 11 01.
Article em En | MEDLINE | ID: mdl-37668600
ABSTRACT

BACKGROUND:

We evaluated the temporal association between kidney function, assessed by estimated glomerular filtration rate (eGFR), and the risk of incident renal cell carcinoma (RCC). We also evaluated whether eGFR could improve RCC risk discrimination beyond established risk factors.

METHODS:

We analyzed the UK Biobank cohort, including 463,178 participants of whom 1,447 were diagnosed with RCC during 5,696,963 person-years of follow-up. We evaluated the temporal association between eGFR and RCC risk using flexible parametric survival models, adjusted for C-reactive protein and RCC risk factors. eGFR was calculated from creatinine and cystatin C levels.

RESULTS:

Lower eGFR, an indication of poor kidney function, was associated with higher RCC risk when measured up to 5 years prior to diagnosis. The RCC HR per SD decrease in eGFR when measured 1 year before diagnosis was 1.26 [95% confidence interval (95% CI), 1.16-1.37], and 1.11 (95% CI, 1.05-1.17) when measured 5 years before diagnosis. Adding eGFR to the RCC risk model provided a small improvement in risk discrimination 1 year before diagnosis with an AUC of 0.73 (95% CI, 0.67-0.84) compared with the published model (0.69; 95% CI, 0.63-0.79).

CONCLUSIONS:

This study demonstrated that kidney function markers are associated with RCC risk, but the nature of these associations are consistent with reversed causality. Markers of kidney function provided limited improvements in RCC risk discrimination beyond established risk factors. IMPACT eGFR may be of potential use to identify individuals in the extremes of the risk distribution.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Insuficiência Renal Crônica / Neoplasias Renais Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Insuficiência Renal Crônica / Neoplasias Renais Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article